🇺🇸 FDA
Patent

US 9850313

Cancer biomarkers and methods of use thereof

granted A61KA61K39/39558A61K45/06

Quick answer

US patent 9850313 (Cancer biomarkers and methods of use thereof) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K39/39558, A61K45/06